{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:56:48Z","timestamp":1791921408891,"version":"4.3.4"},"reference-count":22,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The Monocyte Activation Test (MAT) is an in vitro assay that uses human blood cells to detect both endotoxins and non-endotoxin pyrogens (NEPs), representing a scientifically and ethically superior alternative to the in vivo Rabbit Pyrogen Test (RPT). In the European Pharmacopoeia (Ph. Eur.), the MAT is a compendial method which is explicitly recommended to replace the RPT, requiring only product-specific verification. In contrast, the United States Pharmacopeia (USP) lacks a dedicated MAT chapter, meaning the MAT can only be accepted as an alternative method, given that a full method validation according to USP &lt;1225&gt; is provided in addition to a product-specific verification. This study presents a two-tiered validation strategy addressing both regulatory frameworks: a generic (product-independent) validation aligned with the semi-quantitative test method according to Ph. Eur., ICH Q2, and USP &lt;1225&gt; followed by a product-specific verification. The generic validation consisted of the following parameters: Range and Linearity, Limit of Detection, Accuracy, Specificity, Precision, and Robustness. Robustness was extensively tested under routine-relevant conditions, including variation in the stimulation time, IL-6 read-out timing, freeze\u2013thaw stability, and lot-to-lot comparability. Additionally, an equivalency study of the RPT and the MAT was performed. The data showed that the MAT is at least non-inferior if not superior to the RPT and met the requirements for successful FDA approval of the MAT as an alternative method for pyrogen testing. The MAT was successfully applied to several parenteral drug products. This work provides a transferable framework for GMP-compliant MAT implementation and supports broader international acceptance of the method as a replacement for the RPT in pharmaceutical quality control.<\/jats:p>","DOI":"10.3390\/ijms262211136","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:05:31Z","timestamp":1763463931000},"page":"11136","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Validation of the Monocyte Activation Test Demonstrating Equivalence to the Rabbit Pyrogen Test"],"prefix":"10.3390","volume":"26","author":[{"given":"Luisa","family":"Burgmaier","sequence":"first","affiliation":[{"name":"Microcoat Biotechnologie GmbH, Am Neuland 3, 82347 Bernried am Starnberger See, Germany"},{"name":"Department of Thoracic and Cardiovascular Surgery, University Hospital Tuebingen, Calwerstr. 7\/1, 72076 Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Roche Diagnostics GmbH, Sandhofer Str. 116, 68305 Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gajewi","sequence":"additional","affiliation":[{"name":"Microcoat Biotechnologie GmbH, Am Neuland 3, 82347 Bernried am Starnberger See, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"R\u00f6der","sequence":"additional","affiliation":[{"name":"Microcoat Biotechnologie GmbH, Am Neuland 3, 82347 Bernried am Starnberger See, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1200-870X","authenticated-orcid":false,"given":"Johannes","family":"Reich","sequence":"additional","affiliation":[{"name":"Microcoat Biotechnologie GmbH, Am Neuland 3, 82347 Bernried am Starnberger See, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven M.","family":"Deutschmann","sequence":"additional","affiliation":[{"name":"Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.14573\/altex.1709221","article-title":"Material-mediated pyrogens in medical devices: Applicability of the in vitro Monocyte Activation Test","volume":"35","author":"Borton","year":"2018","journal-title":"ALTEX"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1086\/513856","article-title":"Cytokines as endogenous pyrogens","volume":"179","author":"Dinarello","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jim.2008.03.010","article-title":"Cytokine induction by pyrogens: Comparison of whole blood, mononuclear cells, and TLR-transfectants","volume":"336","author":"Kikkert","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1128\/jcm.29.11.2477-2483.1991","article-title":"Sensitivity of Limulus amebocyte lysate (LAL) to LAL-reactive glucans","volume":"29","author":"Roslansky","year":"1991","journal-title":"J. Clin. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/026119290203002S07","article-title":"Comparison and validation of novel pyrogen tests based on the human fever reaction","volume":"30","author":"Hartung","year":"2002","journal-title":"Altern. Lab. Anim. ATLA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.biologicals.2010.07.003","article-title":"Applicability of bacterial endotoxins test to various blood products by the use of endotoxin-specific lysates","volume":"38","author":"Ochiai","year":"2010","journal-title":"Biologicals"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Misra, G. (2024). Animal-Based Testing Methods and Their Alternatives in Quality Control Evaluation of Biologicals. Quality Control and Regulatory Aspects for Biologicals: Regulations and Best Practices, CRC Press.","DOI":"10.1201\/9781032697444"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"105160","DOI":"10.1016\/j.tiv.2021.105160","article-title":"Standardized pyrogen testing of medical products with the bacterial endotoxin test (BET) as a substitute for rabbit Pyrogen testing (RPT): A scoping review","volume":"74","author":"Spoladore","year":"2021","journal-title":"Toxicol. Vitr. Int. J. Publ. Assoc. BIBRA"},{"key":"ref_9","unstructured":"Atlantic States Marine Fisheries Commission (2018). Species Profile: Horseshoe crab. ASMFC Fish. Focus, 27, Available online: https:\/\/www.google.com\/url?sa=t&source=web&rct=j&opi=89978449&url=https:\/\/archive.asmfc.org\/uploads\/file\/63fd0342FishFocusAugSept2018.pdf&ved=2ahUKEwiv9_7W2viQAxVbQPEDHW9AO5MQFnoECBoQAQ&usg=AOvVaw0ePAmTHzkQNJUF0ehSZHkD."},{"key":"ref_10","unstructured":"European Directorate for the Quality of Medicines & HealthCare (2021). Ph. Eur.: Chapter 2.6.32: Test for Bacterial Endotoxins Using Recombinant Factor C, Council of Europe. [10th ed.]. Supplement 10.3."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Di Paolo, A., Liberti, R., Anzalone, L., Colabella, C., Felici, A., Severi, G., and Cagiola, M. (2024). Recombinant Factor C as an In Vitro Assay for the Residual Pathogenicity Evaluation of Veterinary Autogenous Vaccines. Vet. Sci., 11.","DOI":"10.3390\/vetsci11120673"},{"key":"ref_12","unstructured":"European Directorate for the Quality of Medicines & HealthCare (2024). Ph. Eur.: Chapter 2.6.30 Monocyte-Activation Test, Council of Europe. [11th ed.]. Supplement 11.5."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.14573\/altex.2013.2.169","article-title":"Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test","volume":"30","author":"Hasiwa","year":"2013","journal-title":"ALTEX"},{"key":"ref_14","unstructured":"European Directorate for the Quality of Medicines & HealthCare (2025). Ph. Eur.: General Chapter 5.1.13 Pyrogenicity, Council of Europe. [11th ed.]. Supplement 11.8."},{"key":"ref_15","unstructured":"United States Pharmacopeial Convention (2025, August 22). USP <1225> Validation of Compendial Procedures. Available online: https:\/\/www.ofnisystems.com\/wp-content\/uploads\/2013\/12\/USP36_1225.pdf."},{"key":"ref_16","unstructured":"European Directorate for the Quality of Medicines & HealthCare (2020). Ph. Eur.: Chapter 2.6.30 Monocyte-Activation Test, Council of Europe. [10th ed.]."},{"key":"ref_17","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (2023). ICH Q2(R2) Guideline on Validation of Analytical Procedures, ICH."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biologicals.2021.04.003","article-title":"Development of a rabbit monocyte activation test as an alternative to the rabbit pyrogen test and its application in the analysis of plasma-derived products","volume":"71","author":"Kim","year":"2021","journal-title":"Biologicals"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.yrtph.2015.07.025","article-title":"Assessment of pyrogenic response of lipoteichoic acid by the monocyte activation test and the rabbit pyrogen test","volume":"73","author":"Gimenes","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"J. Appl. Toxicol."},{"key":"ref_21","unstructured":"European Directorate for the Quality of Medicines & HealthCare (2024). Ph. Eur.: Chapter 2.6.40. Monocyte-Activation Test for Vaccines Containing Inherently Pyrogenic Components, Council of Europe. [11th ed.]. Supplement 11.5."},{"key":"ref_22","first-page":"621","article-title":"Validation of the monocyte activation test with three therapeutic monoclonal antibodies","volume":"39","author":"Daniels","year":"2022","journal-title":"ALTEX"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11136\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:05:51Z","timestamp":1763463951000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":22,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262211136"],"URL":"https:\/\/doi.org\/10.3390\/ijms262211136","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]}}}